Reduction of false negative results in screening of newborns for homocystinuria

New England Journal of Medicine

Volumn 341, Issue 21, 1999, Pages 1572-1576

  Peterschmitt, M Judith ^a   Simmons, Jane R ^b   Levy, Harvey L ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b State Laboratory Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE;

ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; HOMOCYSTINURIA; HUMAN; LABORATORY DIAGNOSIS; NEWBORN; NEWBORN SCREENING; PRIORITY JOURNAL; SCREENING TEST;

FALSE NEGATIVE REACTIONS; HOMOCYSTINURIA; HUMANS; INFANT, NEWBORN; METHIONINE; NEONATAL SCREENING; NEW ENGLAND; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0032750462     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199911183412103     Document Type: Article

References (22)

1. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 7th ed. Vol. 1. New York: McGraw-Hill, 1995:1279-327.
2. Kraus JP. Biochemistry and molecular genetics of cystathionine β-synthase deficiency. Eur J Pediatr 1998;157:Suppl 2:S50-S53.
3. Wilcken DE, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis 1997;20: 295-300.
4. Yap S, Naughten E. Homocystinuria due to cystathionine β-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis 1998;21:738-47.
5. Walter JH, Wraith JE, White FJ, Bridge C, Till J. Strategies for the treatment of cystathionine β-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years. Eur J Pediatr 1998;157: Suppl 2:S71-S76.
6. Walraven C, Sorrentino JE, Levy HL, Grady GF. Early newborn specimen: survey of practices among newborn screening programs in the United States. Screening 1995;4:1-8.
7. Levy HL, Shih VE, MacCready RA. Screening for homocystinuria in the newborn and mentally retarded population. In: Carson NAJ, Raine DN, eds. Inherited disorders of sulphur metabolism. Edinburgh, Scotland: Churchill Livingstone, 1971:235-44.
8. Efron ML, Young D, Moser HW, MacCready RA. A simple chromatographic screening test for the detection of disorders of amino acid metabolism. N Engl J Med 1964;270:1378-83.
9. Guthrie R. Screening for "inborn errors of metabolism" in the newborn infant - a multiple test program. In: Bergsma D, ed. Human genetics. Vol. 4. No. 6 of Birth defects original article series. New York: National Foundation-March of Dimes, 1968:92-8.
10. Brattstrom LE, Israelsson B, Jeppsson JO, Hultberg BL. Folk acid -an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 1988;48:215-21.
11. Wagstaff J, Korson M, Kraus JP, Levy HL. Severe folate deficiency and pancytopenia in a nutritionally deprived infant and homocystinuria caused by cystathionine beta-synthase deficiency. J Pediatr 1991;118:569-72.
12. Cunningham CG, Lorcy F, Arnopp J, Patterson M, Currier R. Early discharge trends and their effect on PKU screening. In: Pass KA, Levy HL, eds. Early hospital discharge: impact on newborn screening. Atlanta: Council of Regional Networks for Genetic Services, 1995:31-56.
13. Levy HL, Shih VE, Karolkewicz V, MacCready RA. Screening for phenylketonuria. Lancet 1970;2:522-3.
14. Doherty LB, Rohr FJ, Levy HL. Detection of phenylketonuria in the very early newborn blood specimen. Pediatrics 1991;87:240-4.
15. Naughten ER, Yap S, Mayne PD. Newborn screening for homocystinuria: Irish and world experience. Eur J Pediatr 1998;157:Suppl 2:S84-S87.
16. Whiteman PD, Clayton BE, Ersser RS, Lilly P, Seakins JWT. Changing incidence of neonatal hypermethioninaemia: implications for the detection of homocystinuria. Arch Dis Child 1979;54:593-8.
17. 6-nonresponsive cystathionine β-synthase deficiency and differing blood methionine levels during the neonatal period. J Med Invest 1997;44:95-7.
18. Gaustadnes M, Ingerslev J, Rütiger N. Prevalence of congenital homocystinuria in Denmark. N Engl J Med 1999;340:1513.
19. Morrison AS. Screening in chronic disease. 2nd ed. Vol. 19 of Monographs in epidemiology and biostatistics. New York: Oxford University Press, 1992.
20. Illinois Department of Public Health. Newborn screening: an overview of newborn screening programs in the United States, Canada, Puerto Rico and the Virgin Islands. Springfield, Ill.: Council of Regional Networks for Genetic Services, 1996.
21. Pang S, Clark A. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: newborn screening and its relationship to the diagnosis and treatment of the disorder. Screening 1993;2:105-39.
22. Verkerk PH, Buitendijk SE, Verloove-Vanhorick SP. Congenital hypothyroidism screening and the cutoff for thyrotropin measurement: recommendations from the Netherlands. Am J Public Health 1993;83:868-71.